Nola M. Hylton (born 1957) is an American oncologist who is Professor of Radiology and Director of the Breast Imaging Research Group at the University of California, San Francisco.
She pioneered the usage of magnetic resonance imaging for the detection, diagnosis, and staging of breast cancer by using MRIs to locate tumors and characterize the surrounding tissue.
[8] Nola Hylton played an integral role in the development of MRI technology for the detection and diagnosis of breast cancer.
[10] In the 2013 Investigation of Serial studies to Predict Your Therapeutic Response with Imaging And molecular analysis (I-SPY TRIAL), Hylton developed workstations that allow physicians to perform analyses of breast MRI scans.
She expanded the software to include diffusion-weighted imaging (DW-MRI), which helps assess the response of tumours in patients undergoing preoperative chemotherapy.